Nuage Therapeutics
SpainEntry
2023
Hold
3yr
Status
Active
Who owns Nuage Therapeutics?
Nuage Therapeutics is currently owned by Asabys Partners through Sabadell Asabys Health Innovation Investments II (2023 vintage), since 2023. Across its history, Nuage Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Asabys PartnersSabadell Asabys Health Innovation Investments II · 2023 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2023 · present
Sofinnova PartnersActive
2023 · present(3yr) · Sofinnova Capital X · 2021 · Life Sciences VC
Asabys PartnersActive
2023 · present(3yr) · Sabadell Asabys Health Innovation Investments II · 2023 · Life Sciences VC
More from Sabadell Asabys Health Innovation Investments II
Other portfolio companies in the same fund.
France
BelgiumMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Nuage Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Nuage Therapeutics?
2 strategic and 118financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Nuage Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue